2025

  1. Renata Zelic, Marcus Westerberg, Pär Stattin, Hans Garmo, Lorenzo Richiardi, Olof Akre, Andreas Pettersson. Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer–specific Death in Sweden: A Population-based Cohort Study, European Urology Open Science, 2025. Fulltext
  2. Scilipoti P, Bratt O, Garmo H, Orrason AW, Gedeborg R, Stattin P, Westerberg M. Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate Cancer. J Natl Compr Canc Netw. 2025 Jul. Sammanfattning Fulltext
  3. Ventimiglia, E., Gedeborg, R., Orrason, A. W., Zaurito, P., Garmo, H., Stattin, P., & Westerberg, M.  A comparison of comorbidity indices and estimates of life expectancy for men with prostate cancer. Scandinavian Journal of Urology, 2025 June.
  4. Zaurito, P., Garmo, H., Gedeborg, R., Ahlberg, M., Orrason, A. W., Styrke, J., Robinson, D., Stattin, P., Westerberg, M. (2025). Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study. Scandinavian Journal of Urology. 2025 May. Sammanfattning Fulltext
  5. Strömberg U, Bonander C, Garmo H, Lambe M, Stattin P, Bratt O. Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activity. Acta Oncol. 2025 May. Sammanfattning Fulltext
  6. Ventimiglia E, Gedeborg R, Styrke J, Orrason AW, Stattin P, Westerberg M. Radical Treatment for Prostate Cancer in Men with Limited Life Expectancy. JAMA Network Open. 2025. Sammanfattning Fulltext
  7. Crump C, Stattin P, Brooks JD, Sundquist J, Wei J, Sieh W, Sundquist K. Associations Between Prostate Cancer and Dementia: A Nationwide Study in Sweden. Eur Urol Oncol. 2025 Apr. Sammanfattning Fulltext
  8. Koss Modig K, Arnsrud Godtman R, Carlsson S, Stattin P, Styrke J, Månsson M, Stranne J. Patient- and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study. Eur Urol Oncol. 2025 Apr. Sammanfattning Fulltext
  9. Egevad L, Micoli C, Delahunt B, Samaratunga H, Garmo H, Stattin P, Eklund M. Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancers. J Clin Pathol. 2025 Mar. Sammanfattning
  10. Orrason AW, Scilipoti P, Garmo H, Gedeborg R, Styrke J, Westerberg M. Improved adherence to prostate cancer guidelines concomitant with public reporting. Nationwide population-based study. Scand J Urol. 2025 Feb Sammanfattning Fulltext
  11. Corsini C, Scilipoti P, Orrason AW, Gedeborg R, Westerberg M, Stattin P. Functional outcomes after primary versus delayed robot-assisted radical prostatectomy following active surveillance. JNCI Cancer Spectr. 2025 Feb. Sammanfattning Fulltext
  12. Egevad L, Micoli C, Delahunt B, Samaratunga H, Garmo H, Stattin P, Eklund M. Gleason scores provide more accurate prognostic information than grade groups. Pathology. 2025 Jan. Sammanfattning Fulltext
  13. Scilipoti P, Garmo H, Gedeborg R, Robinson D, Stattin P, Westerberg M. Incidence and prognostic implications of PSA persistence and relapse after radical prostatectomy. Population-based study. J Natl Cancer Inst. 2025 Jan. Sammafattning Fulltext